April 30, 2024
Boehringer Ingelheim Reports Strong Growth in 2023 and Accelerates Late-Stage Pipeline
Boehringer Ingelheim saw a 13% increase in net sales to EUR 779 million in the IMETA region in 2023, driven by new product launches.
